Daniel Clark
Stock Analyst at Leerink Partners
(2.14)
# 2,804
Out of 4,876 analysts
4
Total ratings
66.67%
Success rate
4.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $515 → $580 | $531.32 | +9.16% | 2 | Jun 11, 2025 | |
| ELAN Elanco Animal Health | Initiates: Market Perform | $14 | $14.29 | -2.03% | 1 | Dec 2, 2024 | |
| ZTS Zoetis | Initiates: Outperform | $215 | $156.17 | +37.67% | 1 | Dec 2, 2024 |
IDEXX Laboratories
Jun 11, 2025
Maintains: Outperform
Price Target: $515 → $580
Current: $531.32
Upside: +9.16%
Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $14.29
Upside: -2.03%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $156.17
Upside: +37.67%